MICHAEL BECKLEY is Associate Professor of Political Science at Tufts University, a Nonresident Senior Fellow at the American ...

The gross proceeds from the, before deducting the placement agent’s fees and other offering expenses payable by the Company, are expected to be $3.0 million. Can-Fite intends to use the net proceeds ...

We deeply mourn the passing of R.W. – our family patriarch and one of the visionaries behind Kemin. He was beloved by our ...

A company recently claimed it revived an extinct species, launching a debate across scientific and conservation communities.

Surrey, with over a third of its land designated for farming, is well-positioned to lead the next agricultural revolution.

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will explore whether producing antigens in C1 filamentous fungus—applying ...

Klein and Thompson argue that a world of plenty awaits us if we reform zoning and environmental laws but that can’t be the whole plan, right?

The debate over impoundment — the President’s refusal to spend money appropriated by Congress — has become prominent in our ...

PM Narendra Modi, industrialist Ratan Tata, biotech pioneer Raj Bhan, and mathematician Srinivasa Ramanujan. Gates recalls ...